製薬・創薬 - Patent Detectives

Federal Circuit Affirms ‘pH 13 or Higher’ Means ‘pH 12.98 or Higher’ in Actelion v. Mylan: Generic Epoprostenol Cleared of Infringement

The Federal Circuit on May 13, 2026 affirmed Mylan's generic epoprostenol does not infringe Actelion's Veletri patents, holding 'pH of 13 or higher' means 'pH 12.98 or higher' and foreclosing the doctrine of equivalents under both prosecution history estoppel and the disclosure-dedication rule.

2026.05.18

パテント探偵社編集部

IP News

Trump Invokes Section 232 to Impose 100% Tariff on Patented Pharmaceutical Imports

On April 2, 2026, President Trump signed a Proclamation imposing a 100% tariff on patented pharmaceuticals, their active...

2026.04.13

パテント探偵社編集部

IP News

Trump Executive Order Forces “Patented Manufacturing” Location for Pharmaceuticals: 100% Tariff Decouples IP Strategy from Production Site Freedom

Trump Executive Order Forces "Patented Manufacturing" Location for Pharmaceuticals: 100% Tariff Decouples IP Strategy fr...

2026.04.06

パテント探偵社編集部

IP News

Trump Signs Executive Order Imposing Up to 100% Tariffs on Patented Pharmaceutical Imports Lacking U.S. Manufacturing

President Trump on April 2, 2026, signed an executive order titled “Adjusting Imports of Pharmaceuticals and Pharmaceuti...

2026.04.04

パテント探偵社編集部

IP News